<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>AFib Treatments ‚Äì Rate vs Rhythm Control, Ablation, Anticoagulation</title>
  <meta name="description" content="Atrial fibrillation treatments: rate control, rhythm control, catheter ablation, anticoagulation and risk‚Äëfactor modification. Evidence overview and FAQs.">
  <link rel="canonical" href="https://atrial-fibrillation.org/treatments.html">
  <meta property="og:title" content="AFib Treatments ‚Äì Rate vs Rhythm Control, Ablation, Anticoagulation">
  <meta property="og:description" content="Overview of AFib treatments including rate/rhythm control strategies, ablation, anticoagulation and lifestyle modification.">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://atrial-fibrillation.org/treatments.html">
  <meta property="og:image" content="https://atrial-fibrillation.org/logo.svg">
  <link rel="icon" href="favicon.svg" type="image/svg+xml">
  <link rel="alternate icon" href="favicon.svg">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="styles.min.css?v=3">
  <script type="application/ld+json">
  {
    "@context": "https://schema.org",
    "@type": "FAQPage",
    "mainEntity": [
      {"@type": "Question","name": "Is catheter ablation a cure for AFib?","acceptedAnswer":{"@type":"Answer","text":"Ablation can significantly reduce AFib burden and drug needs, but recurrence may occur and additional procedures can be required. Long‚Äëterm follow‚Äëup is important."}},
      {"@type": "Question","name": "Rate or rhythm control‚Äîwhat is better?","acceptedAnswer":{"@type":"Answer","text":"Both are valid strategies depending on symptoms, duration, comorbidities and patient preference. Early rhythm control and risk‚Äëfactor modification can improve outcomes."}},
      {"@type": "Question","name": "Do I always need anticoagulation?","acceptedAnswer":{"@type":"Answer","text":"Anticoagulation needs are individualized using stroke and bleeding risk scores (e.g., CHA2DS2‚ÄëVASc and HAS‚ÄëBLED). Discuss options with your clinician."}}
    ]
  }
  </script>
</head>
<body>
  <header class="header">
    <nav class="nav">
      <div class="nav-container">
        <div class="nav-logo">
          <a href="index.html#home" class="nav-link">
            <img src="logo.svg" alt="Atrial Fibrillation Logo" class="logo" onerror="this.style.display='none'; this.nextElementSibling.style.display='block';">
            <div class="text-logo" style="display:none;">
              <span style="color:#2563eb;font-weight:bold;font-size:18px;">üíì Atrial Fibrillation</span>
            </div>
          </a>
        </div>
        <ul class="nav-menu">
          <li><a href="index.html#home" class="nav-link">Home</a></li>
          <li><a href="index.html#about" class="nav-link">What is AFib?</a></li>
          <li><a href="treatments.html" class="nav-link">Treatments</a></li>
          <li><a href="index.html#supplements" class="nav-link">Supplements</a></li>
          <li><a href="index.html#research" class="nav-link">Research</a></li>
          <li><a href="index.html#contact" class="nav-link">Contact</a></li>
        </ul>
      </div>
    </nav>
  </header>

  <main style="margin-top:80px;">
    <section class="container" style="padding-top:2rem; padding-bottom:2rem;">
      <div class="section-header">
        <h1>AFib Treatments</h1>
        <p>Rate control, rhythm control, catheter ablation, anticoagulation and lifestyle modification</p>
      </div>
      <!-- Simple overview: four clear paragraphs -->
      <article class="about-card" style="text-align:left; margin-bottom:2rem;">
        <h2>Overview</h2>
        <p><strong>Rate control:</strong> focuses on slowing the ventricular rate to reduce symptoms and improve tolerance of AFib during rest and activity. Typical options include beta‚Äëblockers, diltiazem/verapamil or digoxin depending on blood pressure, heart failure status and exercise needs.</p>
        <p><strong>Rhythm control:</strong> aims to restore and maintain sinus rhythm using antiarrhythmic drugs or cardioversion. Choice of therapy weighs contraindications and proarrhythmia risk; shared decision‚Äëmaking is essential.</p>
        <p><strong>Catheter ablation:</strong> a procedural approach‚Äîoften pulmonary vein isolation‚Äîto eliminate triggers/substrate. Best outcomes in paroxysmal AF; repeat procedures may be necessary.</p>
        <p><strong>Anticoagulation:</strong> personalized stroke prevention guided by CHA2DS2‚ÄëVASc and bleeding risk tools. DOACs are commonly preferred when appropriate; reassess after rhythm interventions.</p>
      </article>

      <article class="about-card" style="text-align:left;">
        <h2>Goals of Treatment</h2>
        <p>AFib care aims to relieve symptoms, improve quality of life, prevent stroke and heart failure, and reduce hospitalizations. Treatment is personalized based on AFib pattern, duration, comorbidities and patient preference, and often combines multiple approaches.</p>

        <h2 id="rate-control">Rate Control</h2>
        <h3>Medications</h3>
        <p>Beta‚Äëblockers, non‚Äëdihydropyridine calcium‚Äëchannel blockers (diltiazem/verapamil) and digoxin can slow AV‚Äënode conduction to keep the ventricular rate in a tolerable range at rest and during activity. Choice depends on blood pressure, heart failure status and exercise requirements.</p>
        <h3>Targets and Monitoring</h3>
        <p>Symptoms and functional status guide targets; some patients do well with lenient control, others need stricter targets. Ambulatory monitoring and exercise assessment can help tailor therapy.</p>

        <h2 id="rhythm-control">Rhythm Control</h2>
        <h3>Antiarrhythmic Drugs</h3>
        <p>Class IC agents (e.g., flecainide, propafenone) and class III agents (e.g., sotalol, dofetilide, amiodarone) are used to maintain sinus rhythm or enable ‚Äúpill‚Äëin‚Äëthe‚Äëpocket‚Äù cardioversion in selected patients. Contraindications, proarrhythmia risk and organ toxicities require careful selection and follow‚Äëup.</p>
        <h3>Cardioversion</h3>
        <p>Electrical or pharmacologic cardioversion can restore sinus rhythm. Anticoagulation strategy depends on AF duration, TEE findings and stroke risk.</p>

        <h2 id="catheter-ablation">Catheter Ablation</h2>
        <h3>Indications</h3>
        <p>PV isolation is effective for symptomatic paroxysmal AF when drug therapy fails or is undesired; persistent AF may require additional substrate ablation. Early referral is increasingly considered, especially in patients seeking rhythm control.</p>
        <h3>Outcomes and Risks</h3>
        <p>Success rates are higher in paroxysmal AF and with risk‚Äëfactor optimization. Complications are uncommon but include vascular injury, tamponade, PV stenosis and rare esophageal injury. Repeat procedures are sometimes needed.</p>

        <h2 id="anticoagulation">Anticoagulation</h2>
        <h3>Stroke and Bleeding Risk</h3>
        <p>Use scores such as CHA2DS2‚ÄëVASc for stroke and HAS‚ÄëBLED for bleeding risk estimation. Direct oral anticoagulants (DOACs) are often preferred over warfarin when not contraindicated. Shared decision‚Äëmaking is central; reassess after rhythm interventions.</p>

        <h2 id="risk-factors">Risk‚ÄëFactor Modification</h2>
        <ul>
          <li>Weight management and metabolic health</li>
          <li>Sleep apnea screening and treatment</li>
          <li>Alcohol moderation and caffeine awareness</li>
          <li>Blood pressure optimization and exercise</li>
          <li>Inflammation and comorbidity management</li>
        </ul>

        <div class="disclaimer" style="margin-top:1.5rem;">
          <p><strong>Medical disclaimer:</strong> This page summarizes common strategies and does not replace individualized medical advice.</p>
        </div>

        <p style="margin-top:1rem;">Related: <a href="taurine.html">Taurine</a> ‚Ä¢ <a href="citrulline.html">L‚Äëcitrulline</a> ‚Ä¢ <a href="index.html#triggers">AFib triggers</a> ‚Ä¢ <a href="index.html#research">Research</a></p>
      </article>
    </section>
  </main>

  <footer class="footer">
    <div class="container">
      <div class="footer-bottom">
        <p>&copy; atrial-fibrillation.org. All rights reserved.</p>
      </div>
    </div>
  </footer>
  <script src="script.min.js?v=3"></script>
</body>
</html>
